Correction to: Relevance of tumor boards for the inclusion of patients in oncological clinical trials (Journal of Cancer Research and Clinical Oncology, (2023), 149, 10, (7601-7608), 10.1007/s00432-022-04559-0)

  • Hendrik Dapper
  • , Maurice Dantes
  • , Peter Herschbach
  • , Hana Algül
  • , Volker Heinemann

Research output: Contribution to journalComment/debate

Abstract

In this article the affiliation details for author Hana Algül were incorrectly given as ‘Department of Internal Medicine II, Comprehensive Cancer Center Munich, Klinikum rechts der Isar, Technical University Munich, Munich, Germany’ but should have been ‘Comprehensive Cancer Center München, Institute for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, Munich, Bavaria, Germany’. The content of the article remains unchanged. The original article has been corrected.

Original languageEnglish
Article number40
JournalJournal of Cancer Research and Clinical Oncology
Volume151
Issue number1
DOIs
StatePublished - Jan 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Relevance of tumor boards for the inclusion of patients in oncological clinical trials (Journal of Cancer Research and Clinical Oncology, (2023), 149, 10, (7601-7608), 10.1007/s00432-022-04559-0)'. Together they form a unique fingerprint.

Cite this